# Phase II Trial of Pentostatin and Targeted Busulfan

> **NCT00496340** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 42 (actual)

## Conditions studied

- Hematologic Malignancies

## Interventions

- **DRUG:** Pentostatin
- **DRUG:** Busulfan
- **DRUG:** Rituximab
- **PROCEDURE:** Allogeneic Hematopoietic Cell Transplant

## Key facts

- **NCT ID:** NCT00496340
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2013-04
- **Final completion:** 2013-08
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2014-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00496340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00496340, "Phase II Trial of Pentostatin and Targeted Busulfan". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00496340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*